MESALAZINE

mesalazine 1 g modified release tablet, 60

MESALAZINE (13576M)

mesalazine 1 g modified release tablet, 60
13576M
Manner of administration:Oral
General Schedule
Restricted Benefit

Restriction

Indication: Ulcerative colitis

Restriction

Indication: Crohn disease
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 4 Max qty units: 240 # of repeats: 5 DPMQ: $266.04 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Pentasa